13
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T0242 | Sitagliptin | MK0431 | Proteasome , DPP-4 , Autophagy |
Sitagliptin (MK0431), a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or in combination with metformin or thiazolidinedion... | |||
T23358 | Sitagliptin phosphate | Januvia,MK-0431 phosphate,Sitagliptin (phosphate) | DPP-4 , Autophagy |
Sitagliptin phosphate (MK-0431 phosphate) is a dipeptidyl peptidase-4 (DPP4) inhibitor. | |||
T5903 | Sitagliptin Intermediate 2 | ||
Sitagliptin Intermediate 2 is a useful organic compound that has been used in life science related research. | |||
T0242L | Sitagliptin phosphate monohydrate | MK-0431,MK-0431 phosphate monohydrate | Proteasome , DPP-4 , Autophagy |
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts. | |||
T40930 | (S)-Sitagliptin phosphate | (S)-Sitagliptin phosphate,(S)-MK-0431 phosphate | |
(S)-Sitagliptin phosphate, the less active S-enantiomer of Sitagliptin phosphate, is a high-potency inhibitor of DPP4. It exhibits an IC50 of 19 nM in Caco-2 cell extracts. | |||
T35637 | Sitagliptin N-Sulfate (sodium salt) | ||
Sitagliptin N-sulfate is a phase II metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor (-)-sitagliptin . Sitagliptin N-sulfate is formed via sulfation and has been found in rat bile following oral administration ... | |||
T35440 | (-)-Sitagliptin Carbamoyl Glucuronide | ||
(-)-Sitagliptin carbamoyl glucuronide is a minor phase II metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor (-)-sitagliptin . (-)-Sitagliptin carbamoyl glucuronide is formed by N-carbamoyl glucuronidation and ha... | |||
T63915 | Sitagliptin fenilalanil | ||
Sitagliptin fenilalanil is a dipeptidyl aminopeptidase (DPP-4) inhibitor. | |||
T74592 | Sitagliptin fenilalanil hydrochloride | ||
Sitagliptin phenylalanine hydrochloride, a dipeptidyl peptidase-4 (DPP-4) inhibitor [1], is a chemical compound utilized in medical applications. | |||
T20028 | Janumet | Efficib,Janumet XR,Metformin / sitagliptin,Metformin hydrochloride mixture with sitagliptin phosphate | |
Metformin hydrochloride mixture with sitagliptin phosphate is an AMP-activated protein kinase stimulant. It is also a CD26 antigen inhibitor, Gluconeogenesis inhibitor, and Glucose modulator. | |||
T63166L | (S, R)-LSN 3318839 | (S, R)-LSN 3318839(Isomer-2764704-18-7) | Glucagon Receptor |
(S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in animal models alone or in combination with sitagliptin. | |||
T70373 | AS2575959 | ||
AS2575959 is a novel GPR40 agonist, exhibiting glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion. | |||
T37522 | Teneligliptin | ||
Teneligliptin (MP-513) is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM. Teneli... |